Press release
Perjeta Market Projected to Reach USD 7.13 Billion by 2034, Growing at a CAGR of 5.3%
Perjeta Market
The report analyzes the Perjeta market to register a CAGR of 5.3% from 2025 to 2034. The market was valued at USD 4.24 billion in 2024 and is projected to grow to USD 7.13 billion by 2034.
Market Introduction
Perjeta, also known as pertuzumab, is a prescription medicine used to treat HER2-positive breast cancer in adults. As a targeted therapy, it specifically attacks HER2 receptors, a protein found on the surface of cancer cells. Perjeta works by binding to the HER2 protein on cancer cells. This prevents it from interacting with other HER receptors, which is crucial for cell growth and survival. Perjeta is used in combination with trastuzumab and chemotherapy (docetaxel) to treat metastatic breast cancer. It is also used in combination with trastuzumab and chemotherapy before or after surgery for locally advanced or early-stage breast cancer. Perjeta is administered as an intravenous infusion (drip) into a vein.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/perjeta-market/request-for-sample
Market Dynamics
Advancements in Treatment Delivery: Advancements in treatment delivery are enhancing the convenience, accessibility, and overall patient experience associated with HER2-targeted therapies. The introduction of fixed-dose combinations and subcutaneous formulations has streamlined the administration process. Also, it has reduced the need for prolonged infusion times and hospital visits. Thus, improvements in treatment delivery are fueling the Perjeta market growth.
Expanding Approvals and Guidelines: Regulatory endorsements for the use of Perjeta in early-stage, neoadjuvant breast cancer settings have solidified their role across several disease progression stages. In addition, treatment protocol updates by global oncology bodies often incorporate Perjeta-based regimes as preferred treatment options, which encourages widespread adoption by healthcare providers.
Market Key Players
The market is witnessing rapid evolution, driven by technological advancements in biosimilars and strategic investments by major market participants. A few of the leading market players are:
• F. Hoffmann-La Roche Ltd
• Biocon
• Samsung Bioepis.
• Pfizer Inc.
• Genentech, Inc.
• Dr. Reddy's Laboratories Ltd.
• CELLTRION INC.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/perjeta-market/request-for-discount-pricing
Perjeta Market Report Highlights
• In terms of product, the monoclonal antibodies segment accounted for a larger revenue share in 2024, owing to their precise targeting mechanism and demonstrated clinical effectiveness in HER2-positive breast cancer treatment.
• Based on distribution channel, the online pharmacies segment is anticipated to register the fastest growth rate during the forecast period, driven by evolving consumer preferences toward digital healthcare solutions and the rising demand for convenient access to specialized medications.
• In 2024, North America held the leading position in the industry, supported by its sophisticated healthcare systems, strong disease awareness, and broad availability of advanced cancer treatments.
• The Asia Pacific Perjeta market is expected to expand at the most rapid pace during the forecast period, driven by increasing health consciousness, advancements in cancer detection technologies, and expanding investments in cancer care facilities.
Segmental Analysis
By Product Outlook
• Monoclonal Antibody
• Generic Drug
By Indication Outlook
• Early Breast Cancer
• Metastatic Breast Cancer
By Distribution Channel Outlook
• Hospital Pharmacies
• Specialty Pharmacies
• Online Pharmacies
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/perjeta-market
Regional Assessment
By region, the report provides industry insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America led the global market in 2024, driven by its high awareness levels, advanced healthcare infrastructure, and widespread access to innovative cancer therapies. Robust clinical research activities and favorable reimbursement environments supporting premium biologics use further contribute to regional market dominance.
Asia Pacific Perjeta is projected to witness the fastest growth from 2025 to 2034, driven by rising healthcare awareness and improving cancer diagnostics. Growing investments in oncology infrastructure and expanding access to advanced treatment modalities also support robust regional market growth.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
U.S. surgical dressings market
https://www.polarismarketresearch.com/industry-analysis/us-surgical-dressings-market
Germany accident insurance market
https://www.polarismarketresearch.com/industry-analysis/germany-accident-insurance-market
Patient Monitoring Devices Market
https://www.polarismarketresearch.com/industry-analysis/patient-monitoring-devices-market
Nucleic Acid Amplification Testing Market
https://www.polarismarketresearch.com/industry-analysis/nucleic-acid-amplification-testing-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Perjeta Market Projected to Reach USD 7.13 Billion by 2034, Growing at a CAGR of 5.3% here
News-ID: 4056302 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Perjeta
Perjeta (Pertuzumab) Market Forecast 2025-2034: Analysing Major Trends, Opportun …
Get 15% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! …
Metastatic HER2 positive Breast Cancer Market: Analysis of Epidemiology, Pipelin …
Metastatic HER2 positive Breast Cancer emerging therapies such as HERCEPTIN, PERJETA, KADCYLA, ENHERTU, and others are expected to boost the Metastatic HER2 positive Breast Cancer Market in the upcoming years.
DelveInsight has launched a new report on "Metastatic HER2 positive Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Metastatic HER2 positive Breast Cancer, historical and forecasted epidemiology as well as the Metastatic HER2…
Transforming the Perjeta (Pertuzumab) Market in 2025: Rising Breast Cancer Incid …
What Is the Expected Size and Growth Rate of the Perjeta (Pertuzumab) Market?_x000D_
The market value of perjeta (pertuzumab) has seen quick expansion in the past few years. From $935.92 million in 2024, it's expected to increase to $1,084.80 million in 2025, with a compound annual growth rate (CAGR) of 15.9%. The rise in the historic phase can be tied down to an upsurge in its application within oncology, the growing…
Obsessive Compulsive Disorder (OCD) Market 2020-2025: Assessment and Growth Oppo …
All information provided in the report is derived from trusted industrial sources. Global Obsessive Compulsive Disorder (OCD) Market research reports finds market figures between 2020 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period.
Global Obsessive Compulsive Disorder (OCD) Market Overview:
This report studies the Global Obsessive Compulsive Disorder (OCD) Market over the forecast period of 2020 to 2025. The Global Obsessive Compulsive Disorder (OCD) Market is expected to…
Exclusive Statistical Report on Immunomodulators Market: Industry to Observe Str …
Overview of Global Immunomodulators Market:
This report provides in-depth study of “Global Immunomodulators Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Immunomodulators Market report also provides an in-depth survey of key players in the market organization.
Some of the major key factors driving the growth of the Global Immunomodulators Market are rapid growth in prevalence of autoimmune diseases, increasing cases of organ transplantation, growing prevalence…
Robust Growth Visible for Obsessive Compulsive Disorder (OCD) Market 2020-2025 | …
This report provides in-depth study on the current state of the Global Obsessive Compulsive Disorder (OCD) Market 2020-2025. Key players in the Global Obsessive Compulsive Disorder (OCD) Market have been identified through the secondary research and their market share has been determined through primary and secondary research. These include a study of annual and financial reports of top players and extensive interviews of leaders including CEOs, directors, and marketing executives.
Global…
